David Najman to Hypoglycemic Agents
This is a "connection" page, showing publications David Najman has written about Hypoglycemic Agents.
Connection Strength
0.498
-
Intensive therapy of type 2 diabetes (ACCORD trial) (OCTOBER 2008). Cleve Clin J Med. 2009 Feb; 76(2):83; author reply 83-4.
Score: 0.273
-
Adverse events related to muraglitazar use in diabetes. JAMA. 2006 May 03; 295(17):1997; author reply 1998.
Score: 0.225